Navigation Links
Global Pain Management Devices Market Report 2013-2018
Date:12/27/2013

DUBLIN, December 27, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/26klw6/pain_management) has announced the addition of the "Global Pain Management Devices Market Report 2013-2018 " report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The global pain management therapeutics market is expected to witness a decline during the forecast period (2012 to 2018) due to patent expirations of the key revenue generating drugs such as Cymbalta (duloxetine) of Eli Lilly & Co. and Lyrica (pregabalin) of Pfizer, Inc. This report studies the global market for pain management therapeutics from three perspectives - therapeutic classes of drugs, indications and geography. Each of these segments is further classified into sub-segments; therapeutic classes include anticonvulsants, antidepressants, anesthetics, NSAIDs, opioids, anti-migraine agents and other non-narcotic analgesics.

The various pain management indications studied in this report include neuropathic pain, fibromyalgia, arthritic pain, chronic back pain, migraine, post-operative pain and cancer pain. Market sizes and forecasts for the period 2010 - 2018 have been provided for each of the segments and sub-segments in terms of USD million, considering 2011 as the base year. The % compound annual growth rate (CAGR) for each market segment for the forecast period (2012 to 2018) has been provided along with market size estimations.

Geographically, the market has been segmented into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The respective market sizes and forecasts have been provided for each of these regions along with the CAGR. The market overview section of the report provides a detailed breakdown of various aspects of market dynamics such as drivers, restraints and opportunities along with market attractiveness analysis and Porter's five force analysis for the pain management therapeutics market.


Key Topics Covered:

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Introduction to Pain Management - Types of Treatments
3.2 World Health Organization's Pain Ladder for cancer
3.3 Market Trends and Future Outlook
3.4 Market Drivers
3.5 Market Restraints
3.6 Market Opportunities
3.7 Porter's Five Forces Analysis
3.8 Market Attractiveness Analysis: Global Pain Management Therapeutics Market, By Geography (2011)

Chapter 4 Global Pain Management Therapeutics Market, by Therapeutic Class
4.1 Anticonvulsants
4.2 Antidepressants
4.3 Anesthetics
4.4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
4.5 Opioids
4.6 Anti-Migraine Agents
4.7 Other Non-Narcotic Analgesics (Acetaminophen)

Chapter 5 Global Pain Management Therapeutics Market, by Indication
5.1 Neuropathic Pain
5.2 Fibromyalgia
5.3 Arthritic Pain
5.4 Chronic Back Pain
5.5 Migraine
5.6 Post-operative pain
5.7 Cancer Pain

Chapter 6 Global Pain Management Therapeutics Market, by Geography
6.1 Overview
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Rest of the World (RoW)

Chapter 7 Competitive Landscape
7.1 Market Share Analysis: Global Pain Management Therapeutics Market (2011)
7.2 Pipeline Snapshot: Pain Management Therapeutics

Chapter 8 Recommendations
8.1 Development of novel combination formulations
8.2 Addressing unmet needs: drug abuse and side-effects
8.3 Generics manufacturers: Investment in emerging markets such as India, China and Russia
8.4 Mergers and acquisitions to enter or strengthen market presence

Chapter 9 Company Profiles


Companies Mentioned:

  • Abbott Laboratories
  • Allergan, Inc
  • Covidien plc
  • Durect Corporation
  • Eli Lilly and Company
  • Endo Health Solutions, Inc
  • Forest Laboratories, Inc
  • GlaxoSmithKline plc
  • Hospira, Inc
  • Johnson & Johnson
  • Merck & Co, Inc
  • Mundipharma International Ltd
  • Novartis International AG
  • NuPathe, Inc
  • Pain Therapeutics, Inc
  • Pfizer, Inc
  • Purdue Pharma LP
  • QRx Pharma Ltd
  • Sanofi
  • Teva Pharmaceutical Industries Limited
  • UCB (Union Chemnique Belge) SA

For more information visit http://www.researchandmarkets.com/research/26klw6/pain_management


Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
2. ConvaTec Donates $10,000 To AAWC Global Volunteers Program Through SAWC Walk For Wellness
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
7. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
8. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
9. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
10. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
11. Global Pharmaceutical Leaders All Converging in Parsippany, New Jersey on September 11-12, 2012 for Breakthrough Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016 The primary goal ... future adoption patterns on the usage of liquid biopsy. ... following: - Timeframe of liquid biopsy adoption ... cfDNA and Evs—by organization type - Sample inflow to ... blood, saliva, stool, serum, and so on. - Correlation ...
(Date:2/11/2016)... 2016 PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial ... 2015. The Company also filed its Quarterly Report on Form ... the Securities and Exchange Commission today. --> ... --> --> Net sales for ... or 95%, to $5.4 million from $2.8 million for the ...
(Date:2/11/2016)... , Feb. 11, 2016  Kindred Biosciences, Inc. ... saving and improving the lives of pets, today announced ... of the New Animal Drug Application (NADA) for Zimeta™ ... field study (KB0120) of Zimeta for the control of ... Company. --> --> ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... The ThedaCare ... San Francisco General Hospital on April 5-7. The series is a multi-day, multi-workshop ... habits. The workshops cover a broad range of topics, including coaching skills, the ...
(Date:2/12/2016)... ... 2016 , ... Fisher House Foundation Chairman and CEO Kenneth Fisher joined Governor ... Alliance president Scott Bensing, and Peggy Kearns Director, VA Southern Nevada Healthcare System yesterday ... This will be the first Fisher House in Nevada, and will provide free lodging ...
(Date:2/12/2016)... ... ... Vail knee specialist Robert LaPrade, MD, PhD was named one of ... of physicians establishing, leading and partnering with ambulatory surgery centers across the United States. ... also known as an ASC, is a modern health care facility focused on providing ...
(Date:2/12/2016)... ... ... Donor Network West, the organ procurement organization that heals lives through organ ... Regional Medical Center. Under the collaboration, the first of its kind, specific organ donors ... certain time frame for donor families for the recovery of organs. , Organ ...
(Date:2/12/2016)... ... 12, 2016 , ... J Thomas & Associates Insurance Agency, ... to act as Agents of Change in the community, announces a new partnership ... to fulfill immediate needs and help them move into permanent housing. Donations to ...
Breaking Medicine News(10 mins):